Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Vitamin D Market – Global Outlook and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The vitamin…
DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Continuous Manufacturing Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. This report insinuates that the…
BEDMINSTER, N.J.–(BUSINESS WIRE)–$TYME–Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that today it…
DUBLIN–(BUSINESS WIRE)–The “Patient Controlled Injectors Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product; Application; Distribution Channel,…
DUBLIN–(BUSINESS WIRE)–The “Urinary Tract Infection Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Drug Class, Indication,…
Inrebic, a once-daily, oral therapy, is the first new treatment option approved in Europe for myelofibrosis in nearly a decade…
Inrebic, a once-daily, oral therapy, is the first new treatment option approved in Europe for myelofibrosis in nearly a decade…
BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting…
BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting…
BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting…